I-Evista (i-Raloxifene HCI) i-Lowers Risk ye-Cancer Invastable Breast Cancer

Yintoni iVista ?:

I-Evista (raloxifene hydrochloride) isistim e-receptor modulator (SERM) ekhethiweyo. Isetyenziselwa ukunyanga i-osteoporosis kwaye ayikho i-hormone.

I-Evista isebenza ngamabhonkco akho kunye neNgcipheko ye-Cancer Inomdla:

I-Evista isetyenziselwa ukuthintela kunye nokunyangwa kwe-osteoporosis (ithambo elincinci) kwintombi yama-postopaopaus. Ngo-2007, kwavunyelwa ukunciphisa umngcipheko wesifo somhlaza wesifuba esingenayo kwi-womenmen postusopausal nge-osteoporosis nakwabasetyhini abasemva kwengozi enkulu yomhlaza webele.

I-Evista ayikho isichengululo somhlaza webele, kodwa ingasetyenziselwa ukunqanda iimeko zesifo somhlaza wesisu se-estrogen-receptor. Akunciphisi umngcipheko wakho wokuphindaphinda umhlaza wesifuba esingenayo. Abasetyhini abanomdlavuza wesibeleko ngenxa yokuguquka kwemfuza ( BRCA1 , BRCA2 ) abayi kuzuza ngokuthatha u-Evista.

I-Evista isebenza njani:

I-Evista ibophelela kwi-estrogen receptors kwiiseli, ukudala ukukhusela kunye nokudala ukujikeleza kwe-estrogen ukuthatha ezinye iindlela ngomzimba wakho. Iyancipha ithambo eliqhelekileyo le-postmenopausal-thinning and increasing the bone of minerals (BMD). Oku kubangela amathambo anamandla kunye nomngcipheko omncinci wezahluko. Inzuzo eyongezelelweyo ye-Evista kukuba iyanciphisa amanqanaba kunye ne- LDL ye-cholesterol . Kwizicubu zebele kunye ne-uterine, zenza njengomchasene we-estrogen.

Amagqabi Ngethuba Ngethuba Lakuba Emva Kwenyuka Kwimizuzu:

Ngexesha nangemva kokumiswa komzimba, umzimba wakho uvelisa i-estrogen encinane, ebangela ukuba ithambo lincinci.

Abasetyhini abaninzi bathabatha i-osteoporosis izidakamizwa ukukhusela nokuqinisa amathambo abo emva kokuphuma kwesisu. I-Fosamax, i-Boniva, kunye ne-Evista imiselwe abo bafazi be-postmenopausal, kunye ne-Vitamin D kunye ne-calcium supplement and exercise-bearing exercise, ukugcina impilo yeethambo kunye nokuthintela i-fractures kunye nekhefu. Ukuba amathambo akho ayancipha, usemngciphekweni weemfucu emgodini, emagqabini, nakubunzima.

Ukuqhathaniswa neTamoxifen:

I-Evista yayifaniswa noTamoxifen kwisifundo se- STAR iminyaka emi-5, kwaye ayifumananga ukuba iyasebenza ngakumbi ekunciphiseni iziganeko zesifo somhlaza wesifuba esingenayo. Nangona kunjalo, unyango lwe-Evista lubangele iimeko ezincinci ze-thrombosis ye-vein, i-pulmonary embolism, i-cataract kunye nomdlavuza we-endometrial (iziphumo eziqhelekileyo eziqhelekileyo) kuneTamoxifen.

Iingcebiso Ngethuba Ukuthatha Ingqiqo:

Abasetyhini abaya kuhlala bengashukumi ixesha elide (ukufumana ukuphucula, ukulala ngokulala, ukuhamba kunye nokuhamba ngokukhawuleza) kufuneka bayeke ukuthabatha u-Evista ubuncinane iiyure ezingama-72 ngaphambili, kunye nexesha, ixesha elidlulileyo. Kungenxa yokuba u-Evista unokunyusa ingozi yegazi. Ukuba uthatha u-Evista, qiniseka ukuthatha i-calcium kunye ne-vitamin D, kunye nokuzibandakanya ngokunyameko, ukuze ufumane inzuzo enkulu kwimpilo yakho yethambo. Yeka okanye unqande ukutshaya , i-caffeine kunye notywala xa uhlala kwi-Evista, njengoko ezo zinto zenza ukuba amathambo ahlambe.

Ngubani Ongafanelanga Ukuthi:

Ungathathi uVevista ukuba:

Maneka ngo:

I-Evista iyatholakala kwiiphilisi ezingama-60 mg, ngokwasemthethweni kuphela. Kuthatyathwa kanye ngosuku, kunye okanye ngaphandle kokutya.

Imiphumela:

Iimeko ezinokubangela ukuba ezi ziphumo eziqhelekileyo:


Akuyena wonke umntu omele athathe u-Evista, njengoko unokunyusa umngcipheko weengcambu zegazi kwimilenze (intlungu ye-vein thrombosis), intliziyo (ukuphambana kwe-pulmonary), kunye namehlo (i-retinal vein thrombosis).

Jonga ugqirha ukuba unayo le mpawu ngelixa uthabatha uVista:

I-Evista ayibangeli intlungu yesisu okanye isisa, kwaye ayibangeli ukuphuma kwegazi.

Imithombo:
Evista.com. I-Osteoporosis kunye neCataltic Breast Inomdla. © 2008.

FDA. Iziko loVavanyo lweMida noPhando. I-FDA iyavuma iiNtsebenziswano ezintsha ze-Evista (raloxifene hydrochloride). Umhla owenziwe: Septemba 17, 2007.

FDA News. Raloxifene hydrochloride. NgoSeptemba 17, 2007.